4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sol-Gel Technologies Ltd. (SLGL) operates in the Biotechnology industry and is headquartered in Ness Ziona, Israel with about 28 employees. Its market capitalization is roughly $248 million. In the fiscal year ended 2025-12-31, SLGL reported $19M in revenue and ($6M) in net income.
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally.
Interactive charts & full statements → Open the SLGL valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $19M | $12M | $2M | $4M | — |
| Operating Income (EBIT) | ($8M) | ($12M) | ($29M) | ($16M) | — |
| Net Income | ($6M) | ($11M) | ($27M) | ($15M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $1M | $0M | $17M | $1M |
| Operating Income (EBIT) | ($4M) | ($3M) | ($6M) | $11M | ($9M) |
| Net Income | ($4M) | ($3M) | ($6M) | $12M | ($9M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $30M | $36M | $45M | $47M | — |
| Total Liabilities | $7M | $7M | $7M | $4M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SLGL viewer.
About TickerBase · Data methodology & sources